Bittium Corporation: Notification of Manager’s Transactions

Report this content

Stock Exchange Release

Free for publication on May 17, 2021 at 2.30 p.m. (CEST+1)

Bittium Corporation: Notification of Manager’s Transactions

Person subject to the notification requirement

Name: Veli-Pekka Paloranta
Position: Member of the Board of Directors

Notification type: Initial Notification
Reference number:  743700NFG5W5I59OVX65_20210514092004_2

Issuer: Bittium Corporation
LEI: 743700NFG5W5I59OVX65

Transaction date: May 12, 2021
Venue: XHEL
Instrument: Share
ISIN: FI0009007264
Nature of transaction: Receipt of a Share-Based Incentive

Transaction details

  1. Volume: 132, unit price: 6.66000 EUR
  2. Volume: 35, unit price: 6.65000 EUR
  3. Volume: 122, unit price: 6.64000 EUR
  4. Volume: 49, unit price: 6.62000 EUR
  5. Volume: 142, unit price: 6.62000 EUR
  6. Volume: 150, unit price: 6.62000 EUR
  7. Volume: 150, unit price: 6.62000 EUR
  8. Volume: 100, unit price: 6.62000 EUR
  9. Volume: 43, unit price: 6.62000 EUR
  10. Volume: 32, unit price: 6.62000 EUR
  11. Volume: 358, unit price: 6.51000 EUR
  12. Volume: 192, unit price: 6.42000 EUR

Aggregated transactions

Volume: 1,505
Volume weighted average price: 6.57415 EUR

 

Oulu, May 17, 2021

Hannu Huttunen
CEO

Further information:

Kari Jokela
Chief Legal Officer
Tel. +358 40 344 5258

Distribution

Nasdaq Helsinki Oy
Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its over 35-year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2020 were EUR 78.4 million and operating profit was EUR 2.1 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com